| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35095-1mg | |||
| Carrier-Free | NBP2-35095-100ug | |||
| Carrier-Free | NBP2-35095-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB7800-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-56275-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 7800-M3-025/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21628-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-22149-50ul | |||
![Immunohistochemistry-Paraffin: CCL19/MIP-3 beta Antibody [NBP2-56275] - Staining in human tonsil and cerebral cortex tissues using anti-CCL19 antibody. Corresponding CCL19 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-Immunohistochemistry-Paraffin-NBP2-56275-img0005.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CCL19/MIP-3 beta Antibody [NBP2-56275] - Staining in human tonsil and cerebral cortex tissues using anti-CCL19 antibody. Corresponding CCL19 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CCL19/MIP-3 beta Antibody [NBP2-56275] - Staining of human tonsil shows high expression.](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-Immunohistochemistry-Paraffin-NBP2-56275-img0004.jpg)
![Immunohistochemistry-Paraffin: CCL19/MIP-3 beta Antibody [NBP2-56275] - Staining of human cerebral cortex shows low expression as expected.](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-Immunohistochemistry-Paraffin-NBP2-56275-img0003.jpg)
![Immunohistochemistry-Paraffin: CCL19/MIP-3 beta Antibody (MM0143-11B4) [NBP2-12097] - 10% Buffer formalin fixed and parffine embedded human placetal tissue section (4um) is subjected IHC staining using NBP2-12097. Tissue section was pretreated in citric buffer (pH 6.0) with microwave for antige retrieval before IHC is applied.](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-MM0143-11B4-Immunohistochemistry-Paraffin-NBP2-12097-img0001.jpg "Immunohistochemistry-Paraffin: CCL19/MIP-3 beta Antibody (MM0143-11B4) [NBP2-12097] - 10% Buffer formalin fixed and parffine embedded human placetal tissue section (4um) is subjected IHC staining using NBP2-12097. Tissue section was pretreated in citric buffer (pH 6.0) with microwave for antige retrieval before IHC is applied.")
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (3A12) [NBP3-15143] - IHC image of CCL19/MIP-3 beta antibody diluted at 1:155 and staining in paraffin-embedded human tonsil tissue. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30 minutes at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-3A12-Immunohistochemistry-NBP3-15143-img0001.jpg "Immunohistochemistry: CCL19/MIP-3 beta Antibody (3A12) [NBP3-15143] - IHC image of CCL19/MIP-3 beta antibody diluted at 1:155 and staining in paraffin-embedded human tonsil tissue. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30 minutes at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.")
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (3A12) [NBP3-15143] - IHC image of CCL19/MIP-3 beta antibody diluted at 1:155 and staining in paraffin-embedded human appendix tissue. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30 minutes at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-3A12-Immunohistochemistry-NBP3-15143-img0002.jpg)
![Western Blot: Macrophage Inflammatory Protein 3 beta Overexpression Lysate (Adult Normal) [NBL1-08848] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for Macrophage Inflammatory Protein 3 beta.](http://images.novusbio.com/fullsize/Macrophage-Inflammatory-Protein-3-beta-Overexpression-Lysate-Adult-Normal-Western-Blot-NBL1-08848-img0002.jpg "Western Blot: Macrophage Inflammatory Protein 3 beta Overexpression Lysate (Adult Normal) [NBL1-08848] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for Macrophage Inflammatory Protein 3 beta.")
![Western Blot: CCL19/MIP-3 beta Antibody (SR1079) [NBP3-21628] - Western blot analysis of extracts from CCL19/MIP-3 beta recombinant protein, using NBP3-21628.](http://images.novusbio.com/fullsize/nbp3-21628_rabbit-ccl19-mip-3-beta-mab-sr1079-57202315234919.jpg "Western Blot: CCL19/MIP-3 beta Antibody (SR1079) [NBP3-21628] - Western blot analysis of extracts from CCL19/MIP-3 beta recombinant protein, using NBP3-21628.")
![Western Blot: CCL19/MIP-3 beta Antibody (SR1080) [NBP3-22149] - Western blot analysis using NBP3-22149 in Human Macrophage Inflammatory Protein 3 beta recombinant protein lysate.](http://images.novusbio.com/fullsize/nbp3-22149_rabbit-ccl19-mip-3-beta-mab-sr1080-57202315584829.jpg "Western Blot: CCL19/MIP-3 beta Antibody (SR1080) [NBP3-22149] - Western blot analysis using NBP3-22149 in Human Macrophage Inflammatory Protein 3 beta recombinant protein lysate.")